$CRTO
Criteo S.A. Stock $crto

$crto Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000157642724000009 Filed on February 23, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$450.1M	$566.3M	$1.949B
YoY Change	1.13%	0.33%	-3.35%
Cost Of Revenue	$196.2M	$289.7M	$1.086B
YoY Change	-12.58%	-8.86%	-0.22%
Gross Profit	$217.2M	$276.6M	$863.0M
YoY Change	19.68%	12.18%	8.53%
Gross Profit Margin	48.27%	48.85%	44.27%
Selling, General & Admin	$140.0M	$131.5M	$494.0M
YoY Change	-0.99%	2.22%	-15.31%
% of Gross Profit	64.45%	47.52%	57.24%
Research & Development	$66.86M	$37.12M	$193.4M
YoY Change	5.14%	-46.48%	3.12%
% of Gross Profit	30.78%	13.42%	22.41%
Depreciation & Amortization	$25.24M	$16.04M	$72.34M
YoY Change	-7.6%	2.72%	30.1%
% of Gross Profit	11.62%	5.8%	8.38%
Operating Expenses	$206.9M	$182.0M	$739.2M
YoY Change	0.91%	-8.07%	-4.11%
Operating Profit	$10.35M	$94.66M	$123.8M
YoY Change	-144.07%	94.6%	410.09%
Interest Expense	$423.0K	-$4.498M	-$2.490M
YoY Change	-12.96%	-29.85%	-222.96%
% of Operating Profit	4.09%	-4.75%	-2.01%
Other Income/Expense, Net	$1.200M	-$8.854M	-$2.500M
YoY Change	-82.35%	-3403.73%	-114.04%
Pretax Income	$11.54M	$83.82M	$74.73M
YoY Change	-169.21%	97.22%	77.67%
Income Tax	$3.000M	$21.77M	$20.08M
% Of Pretax Income	26.01%	25.97%	26.88%
Net Earnings	$7.244M	$61.02M	$53.26M
YoY Change	-161.34%	296.21%	494.94%
Net Earnings / Revenue	1.61%	10.77%	2.73%
Basic Earnings Per Share	$0.13		$0.95
Diluted Earnings Per Share	$0.12	$1.02	$0.88
COMMON SHARES
Basic Shares Outstanding	55.23M shares	56.42M shares	56.17M shares
Diluted Shares Outstanding	59.33M shares		60.23M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$288.9M	$358.9M	$342.3M
YoY Change	-14.45%	-3.86%	-8.3%
Cash & Equivalents	$266.9M	$336.3M	$285.5M
Short-Term Investments	$22.04M	$22.55M	$5.970M
Other Short-Term Assets	$50.13M	$48.29M	$116.0M
YoY Change	-13.74%	-6.89%	65.5%
Inventory
Prepaid Expenses	$35.17M	$32.86M
Receivables	$610.7M	$775.6M	$775.6M
Other Receivables	$152.8M	$118.6M	$118.6M
Total Short-Term Assets	$1.158B	$1.353B	$1.353B
YoY Change	2.96%	7.26%	7.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$116.8M	$126.5M	$239.0M
YoY Change	-20.12%	-3.59%	2.4%
Goodwill	$521.2M	$524.2M
YoY Change	-0.3%	1.76%
Intangibles	$175.3M	$180.9M
YoY Change	-2.57%	2.79%
Long-Term Investments	$16.18M	$21.87M	$21.87M
YoY Change	4.97%	268.91%	268.91%
Other Assets	$60.20M	$60.74M	$113.4M
YoY Change	20.4%	19.53%	-27.97%
Total Long-Term Assets	$1.048B	$1.079B	$1.079B
YoY Change	-1.74%	-0.79%	-0.79%
TOTAL ASSETS
Total Short-Term Assets	$1.158B	$1.353B	$1.353B
Total Long-Term Assets	$1.048B	$1.079B	$1.079B
Total Assets	$2.206B	$2.432B	$2.432B
YoY Change	0.67%	3.53%	3.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$632.4M	$841.9M	$841.9M
YoY Change	5.01%	9.57%	9.57%
Accrued Expenses	$155.1M	$148.7M	$148.7M
YoY Change	16.73%	27.55%	27.55%
Deferred Revenue	$3.230M	$10.00K
YoY Change		0.0%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.946M	$3.389M	$3.389M
YoY Change	17.54%	1447.49%	1447.49%
Total Short-Term Liabilities	$995.0M	$1.180B	$1.180B
YoY Change	0.21%	9.31%	9.31%
LONG-TERM LIABILITIES
Long-Term Debt	$76.00K	$77.00K	$77.00K
YoY Change	0.0%	4.05%	4.05%
Other Long-Term Liabilities	$18.39M	$19.08M	$138.9M
YoY Change	-30.04%	-72.44%	-24.63%
Total Long-Term Liabilities	$138.7M	$140.0M	$139.0M
YoY Change	-6.54%	-25.43%	-24.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$995.0M	$1.180B	$1.180B
Total Long-Term Liabilities	$138.7M	$140.0M	$139.0M
Total Liabilities	$1.134B	$1.321B	$1.352B
YoY Change	-0.67%	4.16%	3.96%
SHAREHOLDERS EQUITY
Retained Earnings	$543.1M	$555.5M
YoY Change	-1.6%	-3.84%
Common Stock	$799.5M	$771.3M
YoY Change	4.86%	4.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$204.4M	$161.8M
YoY Change	-3.33%	-7.17%
Treasury Stock Shares
Shareholders Equity	$1.041B	$1.080B	$1.080B
YoY Change
Total Liabilities & Shareholders Equity	$2.206B	$2.432B	$2.432B
YoY Change	0.67%	3.53%	3.53%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$7.244M	$61.02M	$53.26M
YoY Change	-161.34%	296.21%	494.94%
Depreciation, Depletion And Amortization	$25.24M	$16.04M	$72.34M
YoY Change	-7.6%	2.72%	30.1%
Cash From Operating Activities	$14.02M	$161.3M	$224.2M
YoY Change	-66.6%	28.61%	-12.4%
INVESTING ACTIVITIES
Capital Expenditures	$13.29M	$19.71M	$114.3M
YoY Change	-64.26%	-45.0%	34.81%
Acquisitions	$527.0K		$6.825M
YoY Change	-91.89%		-95.06%
Other Investing Activities	-$606.0K	$15.20M	$5.599M
YoY Change	-155.44%	341.06%	-106.88%
Cash From Investing Activities	-$13.90M	-$4.512M	-$108.7M
YoY Change	-61.5%	-86.07%	-34.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$123.5M
YoY Change			-191.75%
Debt Paid & Issued, Net			$0.00
YoY Change			-100.0%
Cash From Financing Activities	-$62.18M	-22.35M	-147.3M
YoY Change	-13.9%	-70.91%	30.26%
NET CHANGE
Cash From Operating Activities	$14.02M	161.3M	224.2M
Cash From Investing Activities	-$13.90M	-4.512M	-108.7M
Cash From Financing Activities	-$62.18M	-22.35M	-147.3M
Net Change In Cash	-$69.40M	134.5M	-31.72M
YoY Change	2.75%	729.51%	-52.89%
FREE CASH FLOW
Cash From Operating Activities	$14.02M	$161.3M	$224.2M
Capital Expenditures	$13.29M	$19.71M	$114.3M
Free Cash Flow	$724.0K	$141.6M	$109.9M
YoY Change	-84.82%	58.05%	-35.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-2969000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1205000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	59061000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-45157000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-40721000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	81302000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-3856000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	19742000	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-17862000	usd
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	33033000	usd
CY2023	crto	Increase Decrease In Operating Lease Liabilities Assets IncreaseDecreaseInOperatingLeaseLiabilitiesAssets	-696000	usd
CY2022	crto	Increase Decrease In Operating Lease Liabilities Assets IncreaseDecreaseInOperatingLeaseLiabilitiesAssets	748000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1385000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1923000	usd
CY2023	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost Credit Curtailment Gain Loss Statement Of Income Or Comprehensive Income Extensible List DefinedBenefitPlanNetPeriodicBenefitCostCreditCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2023#OperatingExpenses
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	37121000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	13059000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	123150000	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	1756
CY2023	dei	Auditor Name AuditorName	Deloitte & Associés
CY2023	dei	Auditor Location AuditorLocation	Paris-La Défense, France
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	336341000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	348200000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	43300000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	47800000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	775589000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	708949000	usd
CY2023Q4	crto	Prepaid Income Taxes PrepaidIncomeTaxes	2065000	usd
CY2022Q4	crto	Prepaid Income Taxes PrepaidIncomeTaxes	23609000	usd
CY2023Q4	crto	Prepaid Other Taxesand Other Taxes Receivable PrepaidOtherTaxesandOtherTaxesReceivable	109306000	usd
CY2022Q4	crto	Prepaid Other Taxesand Other Taxes Receivable PrepaidOtherTaxesandOtherTaxesReceivable	78274000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	48291000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	51866000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	75000000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	25000000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5970000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	25098000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1352562000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1260996000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	126494000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	131207000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	180888000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	175983000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	524197000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	515140000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	112487000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	102176000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	75000000	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	16575000	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	0	usd
CY2023Q4	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	5294000	usd
CY2022Q4	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	5928000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	60742000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	50818000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	52680000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	31646000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1079357000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1087898000	usd
CY2023Q4	us-gaap	Assets Assets	2431919000	usd
CY2022Q4	us-gaap	Assets Assets	2348894000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	838522000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	742918000	usd
CY2023Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	1467000	usd
CY2022Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	65759000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	17213000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	13037000	usd
CY2023Q4	crto	Financial Liabilities Current FinancialLiabilitiesCurrent	3389000	usd
CY2022Q4	crto	Financial Liabilities Current FinancialLiabilitiesCurrent	219000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	35398000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31003000	usd
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	66659000	usd
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	58031000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	113287000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	85569000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	104552000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	83457000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1180487000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1079993000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1083000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3463000	usd
CY2023Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	4123000	usd
CY2022Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	3708000	usd
CY2023Q4	crto	Financial Liabilities Noncurrent FinancialLiabilitiesNoncurrent	77000	usd
CY2022Q4	crto	Financial Liabilities Noncurrent FinancialLiabilitiesNoncurrent	74000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	83051000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	77536000	usd
CY2023Q4	us-gaap	Loss Contingency Accrual Carrying Value Noncurrent LossContingencyAccrualCarryingValueNoncurrent	32625000	usd
CY2022Q4	us-gaap	Loss Contingency Accrual Carrying Value Noncurrent LossContingencyAccrualCarryingValueNoncurrent	33788000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	19082000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	69226000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	140041000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	187795000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1320528000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1267788000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	25.000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	25.000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	61165663	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61165663	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	61165663	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63248728	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63248728	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	63248728	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2023000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2079000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	5400572	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	5985104	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	161788000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	174293000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	769240000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	734492000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-85326000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-91890000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	555456000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	577653000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1079605000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1048041000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	31786000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	33065000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1111391000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1081106000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2431919000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2348894000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1949445000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2017003000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2254235000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	926839000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1088779000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1333440000	usd
CY2023	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	159562000	usd
CY2022	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	133024000	usd
CY2021	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	138851000	usd
CY2023	us-gaap	Gross Profit GrossProfit	863044000	usd
CY2022	us-gaap	Gross Profit GrossProfit	795200000	usd
CY2021	us-gaap	Gross Profit GrossProfit	781944000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	242289000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	187596000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	151817000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	406012000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	377996000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	325616000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	137525000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	205330000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	152634000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	785826000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	770922000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	630067000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	77218000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	24278000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	151877000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2490000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17783000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1939000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	74728000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	42061000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	153816000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20084000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31186000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16169000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	54644000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	10875000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	137647000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	53259000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	8952000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	134456000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3191000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.95
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.21
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.88
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.09
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56170658	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60004707	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60717446	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60231627	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62760197	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64231637	shares
CY2023	us-gaap	Profit Loss ProfitLoss	54644000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4153000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-59001000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	4153000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-59001000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-61406000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-294000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-3311000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-1374000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-30000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-342000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-169000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	77446000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1152687000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	137647000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-60201000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25473000	usd
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	100043000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	42734000	usd
CY2021	us-gaap	Stockholders Equity Other StockholdersEquityOther	-23000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1198320000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	10875000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-56032000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	431000	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	135685000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	63171000	usd
CY2022	us-gaap	Stockholders Equity Other StockholdersEquityOther	-26000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1081106000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	54644000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4417000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1948000	usd
CY2021Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	175000000.0	usd
CY2021Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2647742	shares
CY2021Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	37.99
CY2021Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	1573696	shares
CY2021Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	1498709	shares
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	280000000	usd
CY2022Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	5135359	shares
CY2022Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	26.43
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	1625742	shares
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	2732386	shares
CY2022Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	480000000	usd
CY2022Q4	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	4286624	shares
CY2022Q4	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	30.0
CY2022Q4	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	2185000	shares
CY2023	us-gaap	Profit Loss ProfitLoss	54644000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	10875000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	137647000	usd
CY2023	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	103369000	usd
CY2022	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	185029000	usd
CY2021	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	124879000	usd
CY2023	crto	Depreciation Depletionand Amortizationand Provisionsfor Various DepreciationDepletionandAmortizationandProvisionsforVarious	72336000	usd
CY2022	crto	Depreciation Depletionand Amortizationand Provisionsfor Various DepreciationDepletionandAmortizationandProvisionsforVarious	150261000	usd
CY2021	crto	Depreciation Depletionand Amortizationand Provisionsfor Various DepreciationDepletionandAmortizationandProvisionsforVarious	90934000	usd
CY2023	us-gaap	Loss Contingency Accrual Payments LossContingencyAccrualPayments	43334000	usd
CY2022	us-gaap	Loss Contingency Accrual Payments LossContingencyAccrualPayments	0	usd
CY2021	us-gaap	Loss Contingency Accrual Payments LossContingencyAccrualPayments	0	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	97185000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	65034000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	44528000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	7929000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	194000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1965000	usd
CY2023	crto	Interest Accrued And Non Cash Financial Income And Expenses InterestAccruedAndNonCashFinancialIncomeAndExpenses	0	usd
CY2022	crto	Interest Accrued And Non Cash Financial Income And Expenses InterestAccruedAndNonCashFinancialIncomeAndExpenses	-259000	usd
CY2021	crto	Interest Accrued And Non Cash Financial Income And Expenses InterestAccruedAndNonCashFinancialIncomeAndExpenses	0	usd
CY2023	crto	Increase Decrease In Unrecognized Tax Benefits IncreaseDecreaseInUnrecognizedTaxBenefits	-880000	usd
CY2022	crto	Increase Decrease In Unrecognized Tax Benefits IncreaseDecreaseInUnrecognizedTaxBenefits	412000	usd
CY2021	crto	Increase Decrease In Unrecognized Tax Benefits IncreaseDecreaseInUnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2344000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	771000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-23588000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3602000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-18642000	usd
CY2023	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	4424000	usd
CY2022	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-10952000	usd
CY2021	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	6043000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2811000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	23646000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-51000	usd
CY2023	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-66233000	usd
CY2022	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-60081000	usd
CY2021	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	41613000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	56344000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	41910000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	134950000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	87937000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	133792000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	82691000	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	8479000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	14687000	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	43815000	usd
CY2021	crto	Increase Decrease In Operating Lease Liabilities Assets IncreaseDecreaseInOperatingLeaseLiabilitiesAssets	-2645000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	224246000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	255985000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	220913000	usd
CY2023	crto	Payments To Acquire Intangible Assets Property Plant And Equipment PaymentsToAcquireIntangibleAssetsPropertyPlantAndEquipment	92501000	usd
CY2022	crto	Payments To Acquire Intangible Assets Property Plant And Equipment PaymentsToAcquireIntangibleAssetsPropertyPlantAndEquipment	84796000	usd
CY2021	crto	Payments To Acquire Intangible Assets Property Plant And Equipment PaymentsToAcquireIntangibleAssetsPropertyPlantAndEquipment	54983000	usd
CY2023	crto	Increase Decreasein Accounts Payable Relatedto Intangible Assets Property Plantand Equipment IncreaseDecreaseinAccountsPayableRelatedtoIntangibleAssetsPropertyPlantandEquipment	-21810000	usd
CY2022	crto	Increase Decreasein Accounts Payable Relatedto Intangible Assets Property Plantand Equipment IncreaseDecreaseinAccountsPayableRelatedtoIntangibleAssetsPropertyPlantandEquipment	28951000	usd
CY2021	crto	Increase Decreasein Accounts Payable Relatedto Intangible Assets Property Plantand Equipment IncreaseDecreaseinAccountsPayableRelatedtoIntangibleAssetsPropertyPlantandEquipment	1973000	usd
CY2023	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	8847000	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2021	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	10419000	usd
CY2023	crto	Paymentsfor Proceedsfrom Changein Other Financial Noncurrent Assets PaymentsforProceedsfromChangeinOtherFinancialNoncurrentAssets	-3577000	usd
CY2022	crto	Paymentsfor Proceedsfrom Changein Other Financial Noncurrent Assets PaymentsforProceedsfromChangeinOtherFinancialNoncurrentAssets	-27753000	usd
CY2021	crto	Paymentsfor Proceedsfrom Changein Other Financial Noncurrent Assets PaymentsforProceedsfromChangeinOtherFinancialNoncurrentAssets	12938000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-76367000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	78513000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	78513000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1249000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1945000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1028000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25196000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	125489000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	135685000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	100027000	usd
CY2023	crto	Proceedsfrom Paymentsfor Changein Other Financial Liabilities ProceedsfromPaymentsforChangeinOtherFinancialLiabilities	235000	usd
CY2022	crto	Proceedsfrom Paymentsfor Changein Other Financial Liabilities ProceedsfromPaymentsforChangeinOtherFinancialLiabilities	-265000	usd
CY2021	crto	Proceedsfrom Paymentsfor Changein Other Financial Liabilities ProceedsfromPaymentsforChangeinOtherFinancialLiabilities	-4037000	usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	22025000	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1920000	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	21878000	usd
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-147254000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-113044000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-80117000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5223000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-44149000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-36913000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-36943000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-67327000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	27516000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	448200000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	515527000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	488011000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	411257000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	448200000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	515527000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	40127000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	38124000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	28767000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1539000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1298000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	1486000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our Consolidated Financial Statements requires the use of estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amount of revenue and expenses during the period. We base our estimates and assumptions on historical experience and other factors that we believe to be reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates. </span></div>On an on-going basis, management evaluates its estimates, primarily those related to: (1) gross vs net assessment in revenue recognition (2) income taxes, (3) assumptions used in the valuation of long-lived assets including intangible assets, and goodwill, (4) assumptions surrounding the recognition and valuation of contingent liabilities and losses.
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1949445000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2017003000	usd
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	reporting_unit
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	reporting_unit
CY2023	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-lived Assets</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset is impaired or the estimated useful life is no longer appropriate. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If indicators of impairment exist and the undiscounted projected cash flows associated with an asset are less than the carrying amount of the asset, an impairment loss is recorded to write the asset down to its estimated fair value. Fair value is estimated based on discounted future cash flows.</span></div>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and accounts receivable. The Company’s cash and cash equivalents are held and foreign exchange contracts are transacted with major financial institutions that the Company's management has assessed to be of high credit quality. The Company has not experienced any losses in such accounts.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company mitigates its credit risk with respect to accounts receivable by performing credit evaluations and monitoring agencies' and advertisers' accounts receivable balances. As of December 31, 2023 an individual customer accounted for 10% or more of accounts receivable. As of December 31, 2022, no individual customer accounted for more than 10% of accounts receivable. During the years ended December 31, 2023, 2022 and 2021, no individual customer represented 10% or more of revenue.</span></div>
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	22963000	usd
CY2023	us-gaap	Payments For Restructuring PaymentsForRestructuring	18591000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	4372000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	1700000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	7600000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	2500000	usd
CY2023	crto	Cir Tax Credits Offset Against Rd Expenses CIRTaxCreditsOffsetAgainstRDExpenses	9500000	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023	us-gaap	Restructuring Charges RestructuringCharges	23000000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2254235000	usd
CY2023	crto	Gross Profit And Other Costs Of Revenue GrossProfitAndOtherCostsOfRevenue	1022606000	usd
CY2022	crto	Gross Profit And Other Costs Of Revenue GrossProfitAndOtherCostsOfRevenue	928224000	usd
CY2021	crto	Gross Profit And Other Costs Of Revenue GrossProfitAndOtherCostsOfRevenue	920795000	usd
CY2023	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	159562000	usd
CY2022	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	133024000	usd
CY2021	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	138851000	usd
CY2023	us-gaap	Gross Profit GrossProfit	863044000	usd
CY2022	us-gaap	Gross Profit GrossProfit	795200000	usd
CY2021	us-gaap	Gross Profit GrossProfit	781944000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	242289000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	187596000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	151817000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	406012000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	377996000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	325616000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	137525000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	205330000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	152634000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	785826000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	770922000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	630067000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	77218000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	24278000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	151877000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2490000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17783000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1939000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	74728000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	42061000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	153816000	usd
CY2023Q4	us-gaap	Cash Cash	285518000	usd
CY2022Q4	us-gaap	Cash Cash	282293000	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	50823000	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	65907000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	336341000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	22545000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	348200000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	25098000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	22545000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	25098000	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	100000000	usd
CY2023Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	22000000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	75000000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	25000000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	75000000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	75000000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	100000000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	818937000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	756741000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	43348000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	47792000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	775589000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	708949000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	47792000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45391000	usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	39899000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	15709000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	18641000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	14433000	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	21027000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	19370000	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	7485000	usd
CY2023	crto	Accounts Receivable Allowance For Credit Loss Other Increase Decrease AccountsReceivableAllowanceForCreditLossOtherIncreaseDecrease	0	usd
CY2022	crto	Accounts Receivable Allowance For Credit Loss Other Increase Decrease AccountsReceivableAllowanceForCreditLossOtherIncreaseDecrease	4733000	usd
CY2021	crto	Accounts Receivable Allowance For Credit Loss Other Increase Decrease AccountsReceivableAllowanceForCreditLossOtherIncreaseDecrease	0	usd
CY2023	crto	Accounts Receivable Allowance For Doubtful Accounts Currency Translation Adjustment Increase Decrease AccountsReceivableAllowanceForDoubtfulAccountsCurrencyTranslationAdjustmentIncreaseDecrease	-874000	usd
CY2022	crto	Accounts Receivable Allowance For Doubtful Accounts Currency Translation Adjustment Increase Decrease AccountsReceivableAllowanceForDoubtfulAccountsCurrencyTranslationAdjustmentIncreaseDecrease	1603000	usd
CY2021	crto	Accounts Receivable Allowance For Doubtful Accounts Currency Translation Adjustment Increase Decrease AccountsReceivableAllowanceForDoubtfulAccountsCurrencyTranslationAdjustmentIncreaseDecrease	1456000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	43348000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	47792000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45391000	usd
CY2023	us-gaap	Proceeds Accounts Receivable Previously Written Off Recovery ProceedsAccountsReceivablePreviouslyWrittenOffRecovery	1400000	usd
CY2023Q4	crto	Prepayments To Suppliers PrepaymentsToSuppliers	7499000	usd
CY2022Q4	crto	Prepayments To Suppliers PrepaymentsToSuppliers	12421000	usd
CY2023Q4	crto	Other Debtors OtherDebtors	7279000	usd
CY2022Q4	crto	Other Debtors OtherDebtors	6768000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	32858000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	24549000	usd
CY2023Q4	crto	Other Assets Current Other OtherAssetsCurrentOther	655000	usd
CY2022Q4	crto	Other Assets Current Other OtherAssetsCurrentOther	8128000	usd
CY2023Q4	crto	Other Assetsand Receivables Gross Current OtherAssetsandReceivablesGrossCurrent	48291000	usd
CY2022Q4	crto	Other Assetsand Receivables Gross Current OtherAssetsandReceivablesGrossCurrent	51866000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	372580000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	361377000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	246086000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	230170000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	126494000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	131207000	usd
CY2023	us-gaap	Depreciation Depreciation	51400000	usd
CY2022	us-gaap	Depreciation Depreciation	55600000	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	415260000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	234372000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	180888000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	357706000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	181723000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	175983000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	48300000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	33400000	usd
CY2023Q4	crto	Other Financial Liabilities Due In Fifth Year OtherFinancialLiabilitiesDueInFifthYear	0	usd
CY2023Q4	crto	Financial Derivatives FinancialDerivatives	2546000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	58240000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	63982000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	39415000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	13477000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2098000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3676000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	180888000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	329699000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	187600000	usd
CY2022	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	0	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-2159000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	515140000	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	5021000	usd
CY2023	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	597000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	4633000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q4	us-gaap	Goodwill Goodwill	524197000	usd
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2023Q4	crto	Other Financial Liabilities OtherFinancialLiabilities	920000	usd
CY2023Q4	crto	Other Financial Liabilities Due In Next Fiscal Year OtherFinancialLiabilitiesDueInNextFiscalYear	843000	usd
CY2023Q4	crto	Other Financial Liabilities Due In Second Year OtherFinancialLiabilitiesDueInSecondYear	77000	usd
CY2023Q4	crto	Other Financial Liabilities Due In Third Year OtherFinancialLiabilitiesDueInThirdYear	0	usd
CY2023Q4	crto	Other Financial Liabilities Due In Fourth Year OtherFinancialLiabilitiesDueInFourthYear	0	usd
CY2023Q4	crto	Derivative Liability Due In Next Fiscal Year DerivativeLiabilityDueInNextFiscalYear	2546000	usd
CY2023Q4	crto	Derivative Liability Due In Second Year DerivativeLiabilityDueInSecondYear	0	usd
CY2023Q4	crto	Derivative Liability Due In Third Year DerivativeLiabilityDueInThirdYear	0	usd
CY2023Q4	crto	Derivative Liability Due In Fourth Year DerivativeLiabilityDueInFourthYear	0	usd
CY2023Q4	crto	Derivative Liability Due In Fifth Year DerivativeLiabilityDueInFifthYear	0	usd
CY2023Q4	crto	Financial Liabilities FinancialLiabilities	3466000	usd
CY2023Q4	crto	Financial Liabilities Due In Next Fiscal Year FinancialLiabilitiesDueInNextFiscalYear	3389000	usd
CY2023Q4	crto	Financial Liabilities Due In Second Year FinancialLiabilitiesDueInSecondYear	77000	usd
CY2023Q4	crto	Financial Liabilities Due In Third Year FinancialLiabilitiesDueInThirdYear	0	usd
CY2023Q4	crto	Financial Liabilities Due In Fourth Year FinancialLiabilitiesDueInFourthYear	0	usd
CY2023Q4	crto	Financial Liabilities Due In Fifth Year FinancialLiabilitiesDueInFifthYear	0	usd
CY2023Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	9245000	usd
CY2022Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	7128000	usd
CY2023Q4	us-gaap	Short Term Lease Cost ShortTermLeaseCost	147000	usd
CY2022Q4	us-gaap	Short Term Lease Cost ShortTermLeaseCost	172000	usd
CY2023Q4	us-gaap	Variable Lease Cost VariableLeaseCost	309000	usd
CY2022Q4	us-gaap	Variable Lease Cost VariableLeaseCost	94000	usd
CY2023Q4	us-gaap	Sublease Income SubleaseIncome	229000	usd
CY2022Q4	us-gaap	Sublease Income SubleaseIncome	401000	usd
CY2023Q4	us-gaap	Lease Cost LeaseCost	9472000	usd
CY2022Q4	us-gaap	Lease Cost LeaseCost	6993000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	36637000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	33284000	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	678000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	681000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	877000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	458000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	921000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	883000	usd
CY2023	us-gaap	Lease Cost LeaseCost	37271000	usd
CY2022	us-gaap	Lease Cost LeaseCost	33540000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	37121000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	24376000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	19911000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	16410000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	12273000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	13059000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	123150000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4702000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	118448000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	38059000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	34964000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	28696000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	22728000	usd
CY2023Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	25914000	usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	16334000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	23315000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	17671000	usd
CY2023Q4	crto	Accounts Payable Capital Expenditures AccountsPayableCapitalExpenditures	3346000	usd
CY2022Q4	crto	Accounts Payable Capital Expenditures AccountsPayableCapitalExpenditures	25414000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	2319000	usd
CY2022Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	2388000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	49648000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	21640000	usd
CY2023Q4	crto	Accounts Payable Accrued Liabilities Employeerelated Payablesand Taxes Payable Current AccountsPayableAccruedLiabilitiesEmployeerelatedPayablesandTaxesPayableCurrent	104552000	usd
CY2022Q4	crto	Accounts Payable Accrued Liabilities Employeerelated Payablesand Taxes Payable Current AccountsPayableAccruedLiabilitiesEmployeerelatedPayablesandTaxesPayableCurrent	83457000	usd
CY2023	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.070
CY2022	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.050
CY2021	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.050
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	16165000	usd
CY2023	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0390
CY2022	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.043
CY2021	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.014
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	44696000	usd
CY2023Q4	crto	Uncertain Tax Liability UncertainTaxLiability	16785000	usd
CY2022Q4	crto	Uncertain Tax Liability UncertainTaxLiability	17980000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2297000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	6550000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	19082000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	69226000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	3708000	usd
CY2021Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	5531000	usd
CY2020Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	6167000	usd
CY2023	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	707000	usd
CY2022	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	1756000	usd
CY2021	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	1324000	usd
CY2023	crto	Defined Benefit Plan Net Periodic Benefit Cost Credit Interest Cost Statement Of Income Or Comprehensive Income Extensible List Not Disclosed Flag DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag	Interest cost
CY2023	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	161000	usd
CY2022	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	73000	usd
CY2021	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	51000	usd
CY2023	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments	306000	usd
CY2022	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments	0	usd
CY2021	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments	0	usd
CY2023	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	290000	usd
CY2022	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	3311000	usd
CY2021	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	1543000	usd
CY2023	us-gaap	Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation	-143000	usd
CY2022	us-gaap	Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation	341000	usd
CY2021	us-gaap	Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation	468000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	4123000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	3708000	usd
CY2021Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	5531000	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	18342000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	17111000	usd
CY2021Q4	us-gaap	Shares Outstanding SharesOutstanding	60675474	shares
CY2022	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	2634619	shares
CY2022	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	1625742	shares
CY2022	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	2732386	shares
CY2022	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	5135359	shares
CY2022Q4	us-gaap	Shares Outstanding SharesOutstanding	57263624	shares
CY2023	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	2083065	shares
CY2023	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	2185000	shares
CY2023	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	4286624	shares
CY2023Q4	us-gaap	Shares Outstanding SharesOutstanding	55765091	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	97185000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	65034000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	44528000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	7864000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5423000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4858000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	97185000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	65034000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	44528000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	7864000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5423000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4858000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	372329	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	43617	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5933	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	3541	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	319238	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.74
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y2M4D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	4.65
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	319238	shares
CY2022Q3	crto	Volume Weighted Average Price Number Of Trading Days VolumeWeightedAveragePriceNumberOfTradingDays	20	day
CY2023Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P4Y
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	302775	shares
CY2023	crto	Class Of Warrant Or Right Granted During Period ClassOfWarrantOrRightGrantedDuringPeriod	0	shares
CY2023	crto	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	58318	shares
CY2023	crto	Class Of Warrant Or Right Canceled During Period ClassOfWarrantOrRightCanceledDuringPeriod	0	shares
CY2023	crto	Class Of Warrant Or Right Expired During Period ClassOfWarrantOrRightExpiredDuringPeriod	0	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	244457	shares
CY2023Q4	crto	Class Of Warrant Or Right Outstanding Weighted Average Grant Date Fair Value ClassOfWarrantOrRightOutstandingWeightedAverageGrantDateFairValue	17.65
CY2023	crto	Class Of Warrant Or Right Vested And Exercisable Weighted Average Remaining Contractual Term ClassOfWarrantOrRightVestedAndExercisableWeightedAverageRemainingContractualTerm	P4Y5M23D
CY2023	crto	Class Of Warrant Or Right Aggregate Intrinsic Value ClassOfWarrantOrRightAggregateIntrinsicValue	9.79
CY2023Q4	crto	Class Of Warrant Or Right Vested And Expected To Vest Exercisable Number ClassOfWarrantOrRightVestedAndExpectedToVestExercisableNumber	244457	shares
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	4678000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1932000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	634000	usd
CY2023	us-gaap	Interest Expense InterestExpense	2244000	usd
CY2022	us-gaap	Interest Expense InterestExpense	2025000	usd
CY2021	us-gaap	Interest Expense InterestExpense	2271000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-7553000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	19659000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1776000	usd
CY2023	crto	Financial Income And Expense Discounting Impact FinancialIncomeAndExpenseDiscountingImpact	5289000	usd
CY2022	crto	Financial Income And Expense Discounting Impact FinancialIncomeAndExpenseDiscountingImpact	4700000	usd
CY2021	crto	Financial Income And Expense Discounting Impact FinancialIncomeAndExpenseDiscountingImpact	0	usd
CY2023	crto	Loss Contingency Accrual Provision Released Not Used LossContingencyAccrualProvisionReleasedNotUsed	-258000	usd
CY2022	crto	Loss Contingency Accrual Provision Released Not Used LossContingencyAccrualProvisionReleasedNotUsed	2258000	usd
CY2021	crto	Loss Contingency Accrual Provision Released Not Used LossContingencyAccrualProvisionReleasedNotUsed	0	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-161000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	730000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2369000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	8337000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-71000	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	2983000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2490000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17783000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1939000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2500000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17800000	usd
CY2022	crto	Financial Income And Expense Discounting Impact FinancialIncomeAndExpenseDiscountingImpact	4700000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	43672000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	27584000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	34811000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	3755000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	5665000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	16549000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	39917000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	21919000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	18262000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-23588000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3602000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-18642000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	634000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	5868000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-9574000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-24222000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2266000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-9068000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20084000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31186000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16169000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.258
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	74728000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	42061000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	153816000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.258
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.258
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.284
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	19295000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	10860000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	43684000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	2376000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	2901000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	4830000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	8764000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2895000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1429000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Beat Amount EffectiveIncomeTaxRateReconciliationBeatAmount	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Beat Amount EffectiveIncomeTaxRateReconciliationBeatAmount	0	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Beat Amount EffectiveIncomeTaxRateReconciliationBeatAmount	6560000	usd
CY2023	crto	Income Tax Reconciliation Nondeductible Provision IncomeTaxReconciliationNondeductibleProvision	-5546000	usd
CY2022	crto	Income Tax Reconciliation Nondeductible Provision IncomeTaxReconciliationNondeductibleProvision	16971000	usd
CY2021	crto	Income Tax Reconciliation Nondeductible Provision IncomeTaxReconciliationNondeductibleProvision	0	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	5274000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	6178000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	6476000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	878000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3190000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1666000	usd
CY2023	crto	Effective Income Tax Rate Reconciliation Loss Carryforward Recognition Amount EffectiveIncomeTaxRateReconciliationLossCarryforwardRecognitionAmount	1760000	usd
CY2022	crto	Effective Income Tax Rate Reconciliation Loss Carryforward Recognition Amount EffectiveIncomeTaxRateReconciliationLossCarryforwardRecognitionAmount	1338000	usd
CY2021	crto	Effective Income Tax Rate Reconciliation Loss Carryforward Recognition Amount EffectiveIncomeTaxRateReconciliationLossCarryforwardRecognitionAmount	10357000	usd
CY2023	crto	Effective Income Tax Rate Reconciliation Value Added Taxes Amount EffectiveIncomeTaxRateReconciliationValueAddedTaxesAmount	1593000	usd
CY2022	crto	Effective Income Tax Rate Reconciliation Value Added Taxes Amount EffectiveIncomeTaxRateReconciliationValueAddedTaxesAmount	1635000	usd
CY2021	crto	Effective Income Tax Rate Reconciliation Value Added Taxes Amount EffectiveIncomeTaxRateReconciliationValueAddedTaxesAmount	2170000	usd
CY2023	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	4341000	usd
CY2022	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	6766000	usd
CY2021	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	25655000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-880000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	412000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	0	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-922000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	201000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	395000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	105000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-151000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-2511000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20084000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31186000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16169000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.269
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.741
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.105
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	67276000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	59322000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	32282000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3602000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-342000	usd
CY2022	crto	Deferred Tax Asset Liability Activity Acquisition Divestitures And Consolidations Increase Decrease DeferredTaxAssetLiabilityActivityAcquisitionDivestituresAndConsolidationsIncreaseDecrease	609000	usd
CY2022	crto	Deferred Tax Asset Liability Activity Other Activity Adjustment Increase Decrease DeferredTaxAssetLiabilityActivityOtherActivityAdjustmentIncreaseDecrease	85000	usd
CY2022	crto	Deferred Tax Asset Liability Activity Currency Translation Adjustments Gain Loss DeferredTaxAssetLiabilityActivityCurrencyTranslationAdjustmentsGainLoss	-849000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	28183000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	59322000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	81391000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	28183000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-23588000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-30000	usd
CY2023	crto	Deferred Tax Asset Liability Activity Acquisition Divestitures And Consolidations Increase Decrease DeferredTaxAssetLiabilityActivityAcquisitionDivestituresAndConsolidationsIncreaseDecrease	0	usd
CY2023	crto	Deferred Tax Asset Liability Activity Other Activity Adjustment Increase Decrease DeferredTaxAssetLiabilityActivityOtherActivityAdjustmentIncreaseDecrease	0	usd
CY2023	crto	Deferred Tax Asset Liability Activity Currency Translation Adjustments Gain Loss DeferredTaxAssetLiabilityActivityCurrencyTranslationAdjustmentsGainLoss	-144000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	51597000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	29800000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	31100000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35000000	usd
CY2022Q4	crto	Unrecognized Tax Benefits Excluding Interest And Penalties UnrecognizedTaxBenefitsExcludingInterestAndPenalties	13315000	usd
CY2021Q4	crto	Unrecognized Tax Benefits Excluding Interest And Penalties UnrecognizedTaxBenefitsExcludingInterestAndPenalties	0	usd
CY2020Q4	crto	Unrecognized Tax Benefits Excluding Interest And Penalties UnrecognizedTaxBenefitsExcludingInterestAndPenalties	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	1086000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	13315000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2023Q4	crto	Unrecognized Tax Benefits Excluding Interest And Penalties UnrecognizedTaxBenefitsExcludingInterestAndPenalties	12229000	usd
CY2022Q4	crto	Unrecognized Tax Benefits Excluding Interest And Penalties UnrecognizedTaxBenefitsExcludingInterestAndPenalties	13315000	usd
CY2021Q4	crto	Unrecognized Tax Benefits Excluding Interest And Penalties UnrecognizedTaxBenefitsExcludingInterestAndPenalties	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	4556000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	4665000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	16785000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	17980000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	16800000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	53259000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	8952000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	134456000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56170658	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60004707	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60717446	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.95
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.21
CY2023	us-gaap	Net Income Loss NetIncomeLoss	53259000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	8952000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	134456000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56170658	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60004707	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60717446	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3905076	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2554516	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3061807	shares
CY2023	crto	Incremental Common Shares Attributableto Dilutive Effectof Sharebased Payment Arrangements Options And Bspce IncrementalCommonSharesAttributabletoDilutiveEffectofSharebasedPaymentArrangementsOptionsAndBSPCE	104294	shares
CY2022	crto	Incremental Common Shares Attributableto Dilutive Effectof Sharebased Payment Arrangements Options And Bspce IncrementalCommonSharesAttributabletoDilutiveEffectofSharebasedPaymentArrangementsOptionsAndBSPCE	117934	shares
CY2021	crto	Incremental Common Shares Attributableto Dilutive Effectof Sharebased Payment Arrangements Options And Bspce IncrementalCommonSharesAttributabletoDilutiveEffectofSharebasedPaymentArrangementsOptionsAndBSPCE	341971	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	51599	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	83040	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	110413	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60231627	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62760197	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64231637	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.88
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.09
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	348675	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	172758	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	312413	shares
CY2023Q2	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	60000000	eur
CY2023Q2	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	65000000	usd
CY2023Q4	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	40000000	eur
CY2023Q4	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	43300000	usd
CY2023	us-gaap	Loss Contingency Accrual Carrying Value Period Increase Decrease LossContingencyAccrualCarryingValuePeriodIncreaseDecrease	-40000000	eur
CY2023	us-gaap	Loss Contingency Accrual Carrying Value Period Increase Decrease LossContingencyAccrualCarryingValuePeriodIncreaseDecrease	-43300000	usd
CY2022Q2	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	60000000	eur
CY2022Q2	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	65000000	usd
CY2023Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	31900000	usd
CY2023Q4	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	3	market
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	307190000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	307382000	usd

Files In Submission

Name	View Source	Status
0001576427-24-000009-index-headers.html	Edgar Link	pending
0001576427-24-000009-index.html	Edgar Link	pending
0001576427-24-000009.txt	Edgar Link	pending
0001576427-24-000009-xbrl.zip	Edgar Link	pending
companyby-lawsasofdecemb.htm	Edgar Link	pending
companyby-lawsasofdecemb001.jpg	Edgar Link	pending
companyby-lawsasofdecemb002.jpg	Edgar Link	pending
companyby-lawsasofdecemb003.jpg	Edgar Link	pending
companyby-lawsasofdecemb004.jpg	Edgar Link	pending
companyby-lawsasofdecemb005.jpg	Edgar Link	pending
companyby-lawsasofdecemb006.jpg	Edgar Link	pending
companyby-lawsasofdecemb007.jpg	Edgar Link	pending
companyby-lawsasofdecemb008.jpg	Edgar Link	pending
companyby-lawsasofdecemb009.jpg	Edgar Link	pending
companyby-lawsasofdecemb010.jpg	Edgar Link	pending
companyby-lawsasofdecemb011.jpg	Edgar Link	pending
companyby-lawsasofdecemb012.jpg	Edgar Link	pending
companyby-lawsasofdecemb013.jpg	Edgar Link	pending
criteo-clawbackpolicyoct.htm	Edgar Link	pending
criteo-clawbackpolicyoct001.jpg	Edgar Link	pending
criteo-clawbackpolicyoct002.jpg	Edgar Link	pending
criteo-clawbackpolicyoct003.jpg	Edgar Link	pending
criteo-clawbackpolicyoct004.jpg	Edgar Link	pending
criteo-clawbackpolicyoct005.jpg	Edgar Link	pending
criteo-clawbackpolicyoct006.jpg	Edgar Link	pending
crto-20231231.htm	Edgar Link	pending
crto-20231231.xsd	Edgar Link	pending
crto-20231231_g1.jpg	Edgar Link	pending
crto-20231231_g2.jpg	Edgar Link	pending
exhibit1021amendmentagre.htm	Edgar Link	pending
exhibit1021amendmentagre001.jpg	Edgar Link	pending
exhibit1021amendmentagre002.jpg	Edgar Link	pending
exhibit1021amendmentagre003.jpg	Edgar Link	pending
exhibit1021amendmentagre004.jpg	Edgar Link	pending
exhibit1021amendmentagre005.jpg	Edgar Link	pending
exhibit1021amendmentagre006.jpg	Edgar Link	pending
exhibit1021amendmentagre007.jpg	Edgar Link	pending
exhibit1021amendmentagre008.jpg	Edgar Link	pending
exhibit1021amendmentagre009.jpg	Edgar Link	pending
exhibit1021amendmentagre010.jpg	Edgar Link	pending
exhibit1021amendmentagre011.jpg	Edgar Link	pending
exhibit1021amendmentagre012.jpg	Edgar Link	pending
exhibit1021amendmentagre013.jpg	Edgar Link	pending
exhibit1021amendmentagre014.jpg	Edgar Link	pending
exhibit1021amendmentagre015.jpg	Edgar Link	pending
exhibit211subsidiariesfy20.htm	Edgar Link	pending
exhibit231deloitteconsentf.htm	Edgar Link	pending
exhibit311ceocertification.htm	Edgar Link	pending
exhibit312cfocertification.htm	Edgar Link	pending
exhibit321ceocfocertificat.htm	Edgar Link	pending
exhibit42-agreementtofurni.htm	Edgar Link	pending
exhibit43-descriptionofsec.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
crto-20231231_def.xml	Edgar Link	unprocessable
crto-20231231_lab.xml	Edgar Link	unprocessable
crto-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
crto-20231231_htm.xml	Edgar Link	completed
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
crto-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRTO
Criteo S.A. Stock $crto

2024 Q1 Form 10-K Financial Statement

#000157642724000009 Filed on February 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTO Criteo S.A. Stock $crto

2024 Q1 Form 10-K Financial Statement

#000157642724000009 Filed on February 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTO
Criteo S.A. Stock $crto